Current perspectives on the clinical implications of oxidative RNA damage in aging research: challenges and opportunities

Zhijie Xu,Jinzhou Huang,Ming Gao,Guijie Guo,Shuangshuang Zeng,Xi Chen,Xiang Wang,Zhicheng Gong,Yuanliang Yan
DOI: https://doi.org/10.1007/s11357-020-00209-w
2020-01-01
GeroScience
Abstract:Ribonucleic acid (RNA) molecules can be easily attacked by reactive oxygen species (ROS), which are produced during normal cellular metabolism and under various oxidative stress conditions. Numerous findings report that the amount of cellular 8-oxoG, the most abundant RNA damage biomarker, is a promising target for the sensitive measurement of oxidative stress and aging-associated diseases, including neuropsychiatric disorders. Most importantly, available data suggest that RNA oxidation has important implications for various signaling pathways and gene expression regulation in aging-related diseases, highlighting the necessity of using combinations of RNA oxidation adducts in both experimental studies and clinical trials. In this review, we primarily describe evidence for the effect of oxidative stress on RNA integrity modulation and possible quality control systems. Additionally, we discuss the profiles and clinical implications of RNA oxidation products that have been under intensive investigation in several aging-associated medical disorders.
What problem does this paper attempt to address?